Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Jun 18, 2018, 06:51 ET SOPHiA GENETICS acquiert Interactive Biosoftware pour stimuler la croissance et accélérer l'adoption de la médecine basée sur les données dans le monde entier

SOPHiA GENETICS, le leader mondial de la médecine basée sur les données (Data-Driven Medicine), a annoncé aujourd'hui à la Conférence européenne...


Jun 18, 2018, 06:30 ET Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...


Jun 18, 2018, 05:45 ET MicroRNA Market Size Worth $626.27 Million by 2025 | CAGR 18.6%: Grand View Research, Inc.

The global microRNA (abbreviated miRNA) market size is expected to reach USD 626.27 million by 2025, according to a new report by Grand View...


Jun 18, 2018, 05:18 ET EMOSIS meldet Alleinvertriebsvereinbarung mit 5-Diagnostics und Kommerzialisierungsbeginn

Emosis startet durch das internationale Netzwerk von 5-Diagnostics den Verkauf von HIT Confirm®, Emosis' erstem Testverfahren. Emosis, ein...


Jun 18, 2018, 04:06 ET SOPHiA GENETICS adquiere Interactive Biosoftware para impulsar el crecimiento

- SOPHiA GENETICS adquiere Interactive Biosoftware para impulsar el crecimiento y acelerar la adopción de medicina impulsada por los...


Jun 18, 2018, 02:45 ET Continued Discussions With FDA on Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study

Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions with the US Food and Drug...


Jun 18, 2018, 02:30 ET NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma's new subsidiary Fortify Therapeutics

NeuroVive Pharmaceutical AB and BridgeBio Pharma today jointly announced that BridgeBio has entered into an exclusive licensing agreement for a...


Jun 17, 2018, 13:22 ET SOPHiA GENETICS erwirbt Interactive Biosoftware, um das Wachstum voranzutreiben und die Einführung datengesteuerter Arzneimittel weltweit zu beschleunigen

SOPHiA GENETICS, das weltweit führende Unternehmen in der datengesteuerten Medizin, gab heute auf der Europäischen Konferenz für Humangenetik...


Jun 17, 2018, 09:07 ET Kanazawa University Research: Lipids and Proteins: Further Evidence for Functional Crosstalk in Cells

Researchers at Kanazawa University have uncovered the role of lipids in facilitating a functional switch between two forms of a cellular enzyme:...


Jun 17, 2018, 06:00 ET Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm

Aprea Therapeutics presented results at the 2018 EHA Annual Meeting from its Phase Ib/II clinical study in MDS. The ongoing study is evaluating the...


Jun 16, 2018, 08:30 ET Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that positive results from the pivotal QuANTUM-R phase 3 study of single...


Jun 16, 2018, 02:00 ET SOPHiA GENETICS Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World

SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has...


Jun 15, 2018, 18:03 ET Study Showcases how Medical Affairs Provides Value to External Stakeholders Such as Payers and Specialty Pharmacies

Medical Affairs has long been a key function within the pharmaceutical industry because of its role in providing medical information to external...


Jun 15, 2018, 13:20 ET JAK Inhibitors Associated with Aggressive Lymphoma

Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat...


Jun 15, 2018, 08:30 ET Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Jun 15, 2018, 08:00 ET Bluebee Achieves ISO 13485 Medical Device Quality Standard Certification

Bluebee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is...


Jun 15, 2018, 08:00 ET Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


Jun 15, 2018, 08:00 ET MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress

MEI Pharma, Inc. (NASDAQ: MEIP) a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and...


Jun 15, 2018, 08:00 ET Foundation Fighting Blindness Clinical Research Institute Hosted Workshop for ProgStar, the Largest Natural History Study for Stargardt Disease Ever Launched

More than 60 leading retinal disease clinical researchers from around the world gathered in Baltimore on June 11, 2018 to discuss findings from...


Jun 15, 2018, 07:31 ET Congresso de Neurologia em Lisboa dedicado à Neurogenética

38% mais mortes devido a doenças neurológicas nos últimos 25 anos: os especialistas pedem o fim das lacunas nos tratamentos O número de pessoas...


Most Viewed

false, false All Products


false, false All Products


false, false All Products


false, false All Products


false, false All Products


false, false All Products


false, false All Products


false, false All Products


false, false All Products


false, false All Products